Jones Lang Lasalle Inc (JLL) 169.56 $JLL JLL to Reinvent

New Post Public Reply Private Reply Replies (0) Message Board

Mar 22, 2015 at 1:28 AM

Jones Lang Lasalle Inc (JLL) 169.56 $JLL

JLL to Reinvent HQ Office
Marketwired - Thu Mar 19, 1:49PM CDT
Consistent with its focus on creating value from real estate, JLL (NYSE: JLL) is putting its own workplace experts to work in coordination with Gensler's architecture and design professionals to revitalize its five-floor headquarters office at Aon Center.
JLL: 169.56 (+5.10)

Jones Lang (JLL) Buys Nextport to Boost Services in Sweden - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 09, 2:00PM CDT
Jones Lang (JLL) has acquired Nextport, a tenant representation and relocation management service provider in Stockholm.
JLL: 169.56 (+5.10), REIS: 26.70 (+0.32), KW: 26.15 (+0.09), LMRK: 17.95 (+0.27)

JLL expands in Sweden
Seeking Alpha - at Seeking Alpha - Thu Mar 05, 9:09AM CST

JLL: 169.56 (+5.10)

JLL Income Property Trust Announces Q4 2014 Earnings Call
Marketwired - Tue Mar 03, 8:01AM CST
Jones Lang LaSalle Income Property Trust, Inc. (NASDAQ: ZIPTAX) (NASDAQ: ZIPTMX) (NASDAQ: ZIPIAX) (NASDAQ: ZIPIMX), an institutionally-managed, non-listed, daily valued perpetual life REIT, will hold a public earnings call on Thursday, March 12, 2015 at 10:00 AM CDT, to review fourth quarter and year-end 2014 operating and financial results. Allan Swaringen, Chief Executive Officer of JLL Income Property Trust, and Gregg Falk, Chief Financial Officer, will present an overview of recent economic events that directly influence the business of the Company and commercial real estate markets, along with a detailed review of the financial performance and more noteworthy accomplishments of the quarter.
JLL: 169.56 (+5.10)

JLL Raises Credit Facility to $2B, Extends Date Till 2020 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 27, 11:00AM CST
In order to bolster its operating flexibility, JLL has made amendments to its existing credit facility.
JLL: 169.56 (+5.10), RESI: 21.19 (+0.13), ALEX: 41.26 (+1.11)

Technical Coverage on Real Estate Management and Development Stocks -- CBRE Group, Forest City Enterprises, Realogy Holdings, E-House China Holdings, and Jones Lang LaSalle
PR Newswire - Wed Feb 18, 7:40AM CST
Editor Note: For more information about this release, please scroll to bottom.
JLL: 169.56 (+5.10), CBG: 36.79 (+1.05), FCE.A: 25.54 (+0.34), RLGY: 44.66 (+0.74), EJ: 5.10 (+0.10)

JLL Named to the Global Outsourcing 100(R) for Seventh Consecutive Year
Marketwired - Tue Feb 17, 7:00AM CST
A strong track record in delivering corporate real estate value through operational efficiency, innovation and leading technology helped JLL (NYSE: JLL) earn a spot on the 2015 Global Outsourcing 100(R). The annual listing published by the International Association of Outsourcing Professionals(R) (IAOP(R)) features the world's best outsourcing service providers across all industries.
JLL: 169.56 (+5.10)

JLL Sees Continued Growth in Fee Revenues: Is it a Hold? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 16, 1:50PM CST
On Feb 13, 2015, we issued an updated research report on JLL.
JLL: 169.56 (+5.10), RESI: 21.19 (+0.13), ALEX: 41.26 (+1.11)

JLL Beats Q4 Earnings on Improved Fee Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 05, 8:40AM CST
JLL reported encouraging fourth-quarter 2014 adjusted earnings of $4.30 per share, beating the Zacks Consensus Estimate of $3.84 per share.
JLL: 169.56 (+5.10), RESI: 21.19 (+0.13), ALEX: 41.26 (+1.11)

Jones Lang LaSalle (JLL) Easily Beats Estimates
Lee Samaha, The Motley Fool - Motley Fool - Tue Feb 03, 6:50PM CST
Real estate services and investment management company Jones Lang LaSalle comfortably beat analyst estimates with its fourth-quarter results and signaled improving conditions within the commercial real estate market. The company offers a range of...
JLL: 169.56 (+5.10)

Jones Lang LaSalle's (JLL) CEO Colin Dyer on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Feb 03, 2:24PM CST

JLL: 169.56 (+5.10)

More on JLL Q4 results
Seeking Alpha - at Seeking Alpha - Tue Feb 03, 7:35AM CST

JLL: 169.56 (+5.10)

Jones Lang Lasalle beats by $0.45, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Feb 03, 6:33AM CST

JLL: 169.56 (+5.10)

JLL Reports Record Full-Year 2014 Adjusted Earnings Per Share of $8.69, Up 38 Percent Over Last Year
Marketwired - Tue Feb 03, 6:31AM CST
Jones Lang LaSalle Incorporated (NYSE: JLL) today reported 2014 adjusted earnings per share of $8.69, up from $6.32 in the prior year. Full-year fee revenue of $4.7 billion was up 18 percent. All percentage variances are calculated on a local currency basis.
JLL: 169.56 (+5.10)

Jones Lang LaSalle Falls 1.37% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Mon Feb 02, 4:59PM CST
Jones Lang LaSalle (NYSE:JLL) traded in a range yesterday that spanned from a low of $144.01 to a high of $147.81. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $146.77 on volume of 813,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
JLL: 169.56 (+5.10)

Jones Lang LaSalle Set to Possibly Rebound After Yesterday's Selloff of 1.37%
Comtex SmarTrend(R) - Mon Feb 02, 4:58PM CST
Jones Lang LaSalle (NYSE:JLL) traded in a range yesterday that spanned from a low of $144.01 to a high of $147.81. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $146.77 on volume of 813,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
JLL: 169.56 (+5.10)

Notable earnings before Tuesday’s open
Seeking Alpha - at Seeking Alpha - Mon Feb 02, 4:30PM CST

CEVA: 21.74 (+0.21), HCLP: 36.41 (+1.41), PNR: 64.64 (+0.26), AET: 108.63 (+0.32), HW: 18.00 (+0.50), UPS: 100.25 (+0.34), NOV: 49.66 (+1.77), JLL: 169.56 (+5.10), ST: 57.45 (+0.54), LYB: 85.53 (+0.51), ACI: 0.90 (-0.05), R: 98.00 (+1.01), TECH: 101.15 (+0.62), SPR: 52.01 (+0.26), BP: 40.10 (+1.13), NYT: 13.78 (+0.04), WDR: 50.56 (+1.29), HRC: 48.01 (-0.31), MNK: 132.47 (+1.26), SC: 23.07 (-0.27), CHD: 86.14 (+0.80), ETN: 68.48 (+0.90), BHE: 24.82 (+0.41), ARG: 107.28 (-5.73), AGCO: 47.58 (+0.26), EMR: 56.69 (+0.42), GLPI: 37.65 (+0.94), CNC: 70.25 (-0.34), HCA: 76.03 (+0.61), MHO: 23.11 (+0.62), CARB: 14.35 (+0.04), AXE: 77.58 (+0.91), IMS: 26.71 (+0.18), GCI: 36.39 (+0.14), LPT: 37.13 (+0.88), CBR: 4.06 (+0.05), ARRY: 8.00 (-0.09), AN: 63.49 (+0.10)

Stropiq Files Applications for Williston Crossing Development With "Dakota Modern" Theme
Marketwired - Mon Feb 02, 2:12PM CST
JLL (NYSE: JLL) - While economic prognosticators debate what impact declining oil prices will have on the oil-laden economies around the word, there is a 219-acre development project in Williston, North Dakota, that is moving forward undeterred. Stropiq, Inc., the international real estate principals behind the most ambitious retail driven, mixed-use project currently underway to serve the residents of the Bakken region, is moving its program forward with the formal filing of its planned design documentation with Williams County of North Dakota.
JLL: 169.56 (+5.10)

Victim or Villain? Real Estate's Role in Market Cycles
Marketwired - Fri Jan 23, 1:00AM CST
A range of strategies is required to limit the economic and social impact that real estate market cycles can cause. An in-depth study of real estate market volatility conducted by JLL (NYSE: JLL) in association with the World Economic Forum describes the policy options and strategies that could manage and possibly limit this impact.
JLL: 169.56 (+5.10)

Landmark Infrastructure (LMRK) Falls: Stock Goes Down 5.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jan 22, 7:51AM CST
Landmark Infrastructure saw a big move last session, as the company’s shares fell by nearly 6% on the day.
JLL: 169.56 (+5.10), LMRK: 17.95 (+0.27)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Compass Unveiled: Power Revolution in Private Equity

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Leapora's Taskeen: Redefining Task Accountability

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

K-Beauty Takes Front Stage at Target Beauty Studio

Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

The Chemical Industry and EPA: A Broken System?

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Sean Trahan Joins Citrin Cooperman: New Tax Lead

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

FJBio Boosts Antibody Discovery with Sapio AI

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...